ZELLUNA ZLNA ADDITIONAL REGULATED INFORMATION REQUIRED TO BE DISCLOSED UNDER THE LAWS OF A MEMBER STATE

Zelluna ASA - Mandatory notification of trade

04. November 2025 kl. 00:35
Original kilde

Reference is made to the private placement (the "Private Placement") and the retail offering through PrimaryBid (the "PrimaryBid Offering") announced by Zelluna ASA on 3 November 2025. Please see the attached PDMR-forms related to (i) allocation of shares in the Private Placement; and (ii) share lending to facilitate settlement of tranche 1 of the Private Placement and the PrimaryBid Offering.

Vedlegg

PDF
20251104 - PDMR attachment.pdf

Andre nyheter

15.01.2026

Zelluna ASA: Approval and publication of prospectus

Les mer →
17.12.2025

Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World's First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours

Les mer →
17.12.2025

Zelluna har nådd en viktig milepæl og innleverer søknad om klinisk studie i Storbritannia for første studie på mennesker av ZI-MA4-1 (ZIMA-101), verdens første MAGE-A4-rettede TCR-NK celleterapi for solide kreftformer.

Les mer →